<div><div><p>[SINGAPORE] The following companies saw new developments that may affect trading of their securities on Tuesday (Aug 19):</p><p>Yangzijiang Financial: The investment holding company said on Monday that it will be the anchor investor in a S$100 million fund by ICH Asset Management, led by Vincent Toe, the Singapore-listed company’s former chief executive. The fund will focus exclusively on Singapore’s small and medium-sized enterprises and is expected to start investing from September this year. The group did not specify the exact sum it would invest in the fund, though it did state the initial pipeline of opportunities include companies from the sectors of healthcare, technology, sustainability, and consumer-services. Shares of Yangzijiang Financial ended Monday flat at S$1.06 before the news. </p><p>Marco Polo Marine: The integrated marine logistics group on Monday posted a 4 per cent decline in gross profit to S$14 million for its third quarter ended Jun 30, 2025, from S$14.6 million in the year-ago period. Its revenue fell 9 per cent on the year to S$31.7 million, from S$34.9 million previously. Shares of Marco Polo Marine ended Monday unchanged at S$0.065, before the announcement.</p><div><div><div><div id="dfp-ad-imu1"></div></div></div></div><p> (CMS): The pharmaceutical company posted a rise in first half profit and declared an interim dividend on Monday, its first set of results after its secondary listing on the Singapore Exchange. Net profit rose 3.4 per cent to 941.2 million yuan (S$168.3 million) compared to the year ago period, as the negative impact of China’s national volume-based procurement policy declined and sales of the group’s products grew. Shares of CMS closed Monday 0.905 per cent or S$0.02 up at S$2.23.</p><p>Clearbridge Health: The healthcare company said on Monday that it has raised S$1.98 million in a fully-subscribed placement of 990 million shares, at S$0.002 each. This has been backed by Singapore fund manager Azure Capital, family office Asdew Acquisitions and veteran investor Ramesh Chandiramani, on plans to enter a new business through the acquisition of  biopharma company Elpis Biopharmaceuticals  for US$330 million.  The placement has allowed Clearbridge to become debt-free, and the proceeds will be used to fund the planned acquisition and for general working capital. The counter ended Monday flat at S$0.004 before the news. </p></div><div>Stocks to watchSingapore stock marketSingapore Stocks</div><div><section><section><p>Share with us your feedback on BT's products and services</p><div>Feedback</div></section></section></div><div><div><div><div id="dfp-ad-imu1"></div></div></div></div></div>

9RQR

明策集團

<p>在 8 月 19 日，新加坡的幾家公司報告了影響其股票的重要進展。揚子江金融將成為一隻專注於中小企業的 1 億新元基金的主要投資者。馬可波羅海洋報告第三季度毛利潤下降 4%。中國醫療系統宣佈上半年利潤增長 3.4%，並宣告派發中期股息。明策集團為計劃收購 Elpis 生物製藥籌集了 198 萬新元，並在此過程中實現了無債務狀態。在公告發布之前，大多數公司的股票保持穩定</p>

值得關注的股票包括：揚子江金融、馬可波羅海運、中國醫療系統以及明策健康